On the public citation graph

Newly Diagnosed Systemic Lupus Erythematosus after Sars-Cov-2 Vaccination: Coincidental or Relevant?

0 signed · 13 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s10067-021-05963-6openalex-extracted

Adverse events and disease flares after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus

inferredcites →https://doi.org/10.1016/j.jaut.2022.102898openalex-extracted

Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review

inferredcites →https://doi.org/10.1016/s1473-3099(22)00320-6openalex-extracted

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

inferredcites →https://doi.org/10.1016/s2665-9913(21)00221-6openalex-extracted

Tolerance of COVID-19 vaccination in patients with systemic lupus erythematosus: the international VACOLUP study

inferredcites →https://doi.org/10.1038/s41577-021-00526-xopenalex-extracted

COVID-19 vaccines: modes of immune activation and future challenges

inferredcites →https://doi.org/10.1056/nejmoa1912196openalex-extracted

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

inferredcites →https://doi.org/10.1084/jem.20201387openalex-extracted

SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4

inferredcites →https://doi.org/10.1136/lupus-2022-000727openalex-extracted

Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus

inferredcites →https://doi.org/10.1172/jci.insight.122312openalex-extracted

Integrated, multicohort analysis reveals unified signature of systemic lupus erythematosus

inferredcites →https://doi.org/10.3389/fimmu.2022.801522openalex-extracted

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations

inferredcites →https://doi.org/10.3390/biology10090829openalex-extracted

Type I Interferons in COVID-19 Pathogenesis

inferredcites →https://doi.org/10.3390/ijms222011286openalex-extracted

The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases

inferredcites →https://doi.org/10.3390/ijms23052505openalex-extracted

Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.